Orwin Says Affymax Entering $2 Billion Dialysis Market
416 views · Published 27 June 2011 · 2:44 · Indexed 30 October 2026
Channel: Bloomberg Originals · 2011 · Entertainment
June 27 (Bloomberg) -- John Orwin, chief executive officer of Affymax Inc., talks about the company's efforts to secure FDA approval for its first product, a drug used in the treatment of kidney dialysis patients with anemia. Orwin also discusses drug pricing strategy.
Orwin speaks with Shannon Pettypiece at the 2011 BIO International Convention in Washington on Bloomberg Television's "Street Smart." (Source: Bloomberg)
More from this channel
-
3:30
Market Close 6.4 - Bloomberg
-
0:17
Pens Tie Stanley Cup Series - Bloomberg
-
0:35
Hardware Price Too High - Activision - Bloomberg
-
0:31
FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg
-
0:44
Bank Have More Accounting Leeway - Bloomberg
-
0:32
Lakers Beat Magic 100-75 - Bloomberg
-
0:30
Johnson Wins 300th Game - Bloomberg
-
1:13
GM Expects To Sell Saturn To Penske Automotive - Bloomberg